FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110110080> ?p ?o ?g. }

• W2110110080 endingPage "214" @default.
• W2110110080 startingPage "207" @default.
• W2110110080 abstract "Drug-eluting stents (DES) were developed to combat the problem of in-stent restenosis, and evaluating the biological activity from DES systems is critical for its safety and efficacy. To test the cytotoxicity of nitric oxide (NO) donor-containing polymers for their potential use in DES applications, S-nitrosoglutathione (GSNO) or in combination with poly(vinyl alcohol) (PVA) and poly(vinyl pyrrolidone) (PVP) in an aqueous polymeric solution (PVA/PVP/GSNO) was investigated using Balb/c 3T3 and Rabbit arterial smooth muscle (RASM) cells. The sensitivity of 3T3 cells to the cytotoxicity effects induced by GSNO was higher than that of RASM cells, while RASM cells were more susceptible to alterations in membrane permeability. Cell growth assays showed that GSNO and PVA/PVP/GSNO induced antiproliferative effects in RASM cells. Moreover, the presence of polymers can reduce the cytotoxicity and enhance the antiproliferative effects of GSNO. Dose-dependent inhibition of platelet aggregation was similar for both PVA/PVP/GSNO (EC50 of 3.4 ± 2.3 µM) and GSNO (EC50 of 2.8 ± 1.1 µM) solutions. Platelet adhesion assays showed that the inhibition caused by GSNO (EC50 of 5.0 mM) was dependent on the presence of plasma. These results demonstrate that the methodology adopted here is suitable to establish safety margins and evaluate the antithrombotic potential and antiproliferative effects of NO-eluting biomaterials and polymeric solutions for the new cardiovascular devices, and also to emphasize the importance of using more specific cell lines in these evaluations." @default.
• W2110110080 created "2016-06-24" @default.
• W2110110080 creator A5001992298 @default.
• W2110110080 creator A5014439746 @default.
• W2110110080 creator A5025630784 @default.
• W2110110080 creator A5041617090 @default.
• W2110110080 creator A5066516732 @default.
• W2110110080 creator A5074836284 @default.
• W2110110080 date "2011-03-04" @default.
• W2110110080 modified "2023-10-02" @default.
• W2110110080 title "In vitro evaluation of the safe margin, antithrombotic and antiproliferative actions for the treatment of restenosis: Nitric oxide donor and polymers" @default.
• W2110110080 cites W120853462 @default.
• W2110110080 cites W1490250650 @default.
• W2110110080 cites W1964907994 @default.
• W2110110080 cites W1982202824 @default.
• W2110110080 cites W1984088653 @default.
• W2110110080 cites W1996823382 @default.
• W2110110080 cites W1997895087 @default.
• W2110110080 cites W1998323951 @default.
• W2110110080 cites W2007829166 @default.
• W2110110080 cites W2027993989 @default.
• W2110110080 cites W2032996948 @default.
• W2110110080 cites W2033708409 @default.
• W2110110080 cites W2036463603 @default.
• W2110110080 cites W2046001871 @default.
• W2110110080 cites W2051195797 @default.
• W2110110080 cites W2052070213 @default.
• W2110110080 cites W2055546971 @default.
• W2110110080 cites W2057764953 @default.
• W2110110080 cites W2059930779 @default.
• W2110110080 cites W2064030465 @default.
• W2110110080 cites W2068898439 @default.
• W2110110080 cites W2071154318 @default.
• W2110110080 cites W2073625171 @default.
• W2110110080 cites W2081376324 @default.
• W2110110080 cites W2083630382 @default.
• W2110110080 cites W2086307290 @default.
• W2110110080 cites W2088686339 @default.
• W2110110080 cites W2091038786 @default.
• W2110110080 cites W2091949587 @default.
• W2110110080 cites W2093091015 @default.
• W2110110080 cites W2094527163 @default.
• W2110110080 cites W2095341873 @default.
• W2110110080 cites W2097512416 @default.
• W2110110080 cites W2101848599 @default.
• W2110110080 cites W2118555638 @default.
• W2110110080 cites W2119785324 @default.
• W2110110080 cites W2120429691 @default.
• W2110110080 cites W2127454771 @default.
• W2110110080 cites W2128281308 @default.
• W2110110080 cites W2142286991 @default.
• W2110110080 cites W2143004446 @default.
• W2110110080 cites W2164408275 @default.
• W2110110080 cites W2209073117 @default.
• W2110110080 cites W2331449048 @default.
• W2110110080 cites W98265532 @default.
• W2110110080 doi "https://doi.org/10.1002/cbf.1738" @default.
• W2110110080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21374644" @default.
• W2110110080 hasPublicationYear "2011" @default.
• W2110110080 type Work @default.
• W2110110080 sameAs 2110110080 @default.
• W2110110080 citedByCount "12" @default.
• W2110110080 countsByYear W21101100802012 @default.
• W2110110080 countsByYear W21101100802013 @default.
• W2110110080 countsByYear W21101100802015 @default.
• W2110110080 countsByYear W21101100802016 @default.
• W2110110080 countsByYear W21101100802018 @default.
• W2110110080 countsByYear W21101100802019 @default.
• W2110110080 crossrefType "journal-article" @default.
• W2110110080 hasAuthorship W2110110080A5001992298 @default.
• W2110110080 hasAuthorship W2110110080A5014439746 @default.
• W2110110080 hasAuthorship W2110110080A5025630784 @default.
• W2110110080 hasAuthorship W2110110080A5041617090 @default.
• W2110110080 hasAuthorship W2110110080A5066516732 @default.
• W2110110080 hasAuthorship W2110110080A5074836284 @default.
• W2110110080 hasConcept C109316439 @default.
• W2110110080 hasConcept C126322002 @default.
• W2110110080 hasConcept C178790620 @default.
• W2110110080 hasConcept C181199279 @default.
• W2110110080 hasConcept C185592680 @default.
• W2110110080 hasConcept C202751555 @default.
• W2110110080 hasConcept C2776015013 @default.
• W2110110080 hasConcept C2777015399 @default.
• W2110110080 hasConcept C2780666587 @default.
• W2110110080 hasConcept C519581460 @default.
• W2110110080 hasConcept C521977710 @default.
• W2110110080 hasConcept C538909803 @default.
• W2110110080 hasConcept C55493867 @default.
• W2110110080 hasConcept C71924100 @default.
• W2110110080 hasConcept C98274493 @default.
• W2110110080 hasConceptScore W2110110080C109316439 @default.
• W2110110080 hasConceptScore W2110110080C126322002 @default.
• W2110110080 hasConceptScore W2110110080C178790620 @default.
• W2110110080 hasConceptScore W2110110080C181199279 @default.
• W2110110080 hasConceptScore W2110110080C185592680 @default.
• W2110110080 hasConceptScore W2110110080C202751555 @default.
• W2110110080 hasConceptScore W2110110080C2776015013 @default.
• W2110110080 hasConceptScore W2110110080C2777015399 @default.

• next